文献速递瓣膜外科先天性心脏病外科

二尖瓣前叶长度对梗阻性肥厚型心肌病室间隔心肌切除术结局的重要性

Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy?
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-01-21

该研究回顾了564例接受经主动脉室间隔心肌切除术的梗阻性肥厚型心肌病患者,术中测量二尖瓣叶长度,并与冠脉搭桥和主动脉瓣置换患者比较。发现肥厚型心肌病患者二尖瓣叶稍长(约5 mm),但前叶长度与左室流出道压差、压差缓解及1年死亡率无关。因此,在无 intrinsic 二尖瓣疾病时,仅行扩大室间隔心肌切除术即可。

要点

  • 肥厚型心肌病患者二尖瓣叶较无肥厚型心肌病者稍长(约5 mm)。
  • 前叶长度与术前静息左室流出道压差无关(P=.76)。
  • 前叶长度与术后压差缓解及1年死亡率无关(P=.36;P=.758)。

核心结论

  • 肥厚型心肌病患者二尖瓣叶存在轻度延长,但前叶长度不影响室间隔心肌切除术后的左室流出道压差缓解或1年生存。
  • 在无 intrinsic 二尖瓣疾病时,经主动脉扩大室间隔心肌切除术(切除超过室间隔接触点)对几乎所有患者已足够。

研究设计与样本

  • 回顾性队列研究,纳入2015年2月至2018年4月间564例因梗阻性肥厚型心肌病接受经主动脉室间隔心肌切除术的患者。
  • 对照组为同期90例孤立冠脉搭桥患者和92例主动脉瓣置换患者,均行术中经食管超声测量二尖瓣叶长度及对合长度。

主要发现

  • 肥厚型心肌病组二尖瓣叶测量值均显著长于冠脉搭桥组和主动脉瓣置换组(P < .001)。
  • 术前静息左室流出道压差与前叶长度无关:<30 mm组中位压差49(21, 81.5)mm Hg vs ≥30 mm组50.5(21, 77)mm Hg,P = .76。
  • 压差降低与前叶长度无关:<30 mm组中位降低33(69, 6)mm Hg vs ≥30 mm组36.5(62, 6)mm Hg,P = .36。
  • 前叶长度与1年死亡率增加无关(P = .758)。

关键数值与推荐

  • 患者中位年龄60.3(50.2-67.7)岁,男性占54.1%。
  • 同期行二尖瓣修复36例(6.4%),二尖瓣置换8例(1.4%),主要因 intrinsic 二尖瓣疾病。

临床怎么用

  • 对于梗阻性肥厚型心肌病行室间隔心肌切除术,无需常规行前叶折叠术。
  • 手术应聚焦于扩大切除范围超过室间隔接触点,以缓解左室流出道梗阻。
  • 仅当存在 intrinsic 二尖瓣疾病时才考虑同期二尖瓣修复或置换。

局限性

  • 回顾性研究设计。
  • 单中心经验,结果需外推谨慎。
  • 未报告长期随访结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Elongation of mitral valve leaflets is a phenotypic feature of hypertrophic cardiomyopathy, and some surgeons advocate plication of the anterior leaflet at the time of septal myectomy. The present study investigates mitral valve leaflet length and outcomes of patients undergoing septal myectomy for obstructive hypertrophic cardiomyopathy. METHODS: We reviewed the records and echocardiograms of 564 patients who underwent transaortic septal myectomy for obstructive hypertrophic cardiomyopathy between February 2015 and April 2018. Extended septal myectomy without plication of the anterior leaflet was the standard procedure. From intraoperative prebypass transesophageal echocardiograms, we measured anterior and posterior mitral valve leaflets and their coaptation length. For comparison, we performed these mitral valve leaflet measurements in 90 patients who underwent isolated coronary artery bypass grafting and 92 patients undergoing aortic valve replacement in the same period. Among patients with hypertrophic cardiomyopathy undergoing septal myectomy, we assessed left ventricular outflow tract gradient relief and 1-year survival in relation to leaflet length. RESULTS: Median patient age (interquartile range) was 60.3 (50.2-67.7) years, and 54.1% were male. Concomitant mitral valve repair was performed in 36 patients (6.4%), and mitral valve replacement was performed in 8 patients (1.4%), primarily for intrinsic mitral valve disease. Patients in the hypertrophic cardiomyopathy cohort had significantly longer mitral valve leaflet measurements compared with patients undergoing coronary artery bypass grafting or aortic valve replacement (P < .001 for all 3 measurements). Preoperative resting left ventricular outflow tract gradients were not related to leaflet length (<30 mm, median 49 [21, 81.5] mm Hg vs ≥30 mm, 50.5 [21, 77] mm Hg; P = .76). Further, gradient reduction after myectomy was not related to leaflet length; patients with less than 30 mm anterior leaflet length had a median gradient reduction of 33 (69, 6) mm Hg compared with 36.5 (62, 6) mm Hg for patients with leaflet length 30 mm or more (P = .36). Anterior mitral valve leaflet length was not associated with increased 1-year mortality (P = .758). CONCLUSIONS: Our study confirms previous findings that patients with hypertrophic cardiomyopathy have slight (5 mm) elongation of mitral valve leaflets. In contrast to other reports, increased anterior mitral valve leaflet length was not associated with higher left ventricular outflow tract gradients. Importantly, we found no significant relationship between anterior mitral valve leaflet length and postoperative left ventricular outflow tract resting gradients or gradient relief. Thus, in the absence of intrinsic mitral valve disease, transaortic septal myectomy with focus on extending the excision beyond the point of septal contact is sufficient for almost all patients.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Lentz Carvalho J, Schaff HV, Nishimura RA, et al. Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy? J Thorac Cardiovasc Surg. 2021. PMID: 33632527. doi:10.1016/j.jtcvs.2020.12.143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。